Alloy Therapeutics, Inc. news

Alloy Therapeutics, a biotechnology ecosystem company empowering the global scientific community to make better medicines together, today announced the close of a $75 million Series C financing round. The round was led by 8VC, Presight Capital, and Peter Thiel with participation from new investors including Mubadala Capital, the asset management arm of Mubadala Investment Company, an unnamed sovereign wealth fund, Founders Fund and Gai

“We are excited to partner with the BaseLaunch team and support their continued success developing a vibrant hub for biotechnology innovation in the Basel Area,” said Errik Anderson, chief executive and founder of Alloy Therapeutics. “At Alloy, we are singularly focused on supporting scientists developing new medicines for patients by democratizing access to foundational drug discovery platforms and services. BaseLaunch’s offering of company building capabilities is a